Provided by Tiger Trade Technology Pte. Ltd.

COLLPLANT BIOTECHNOLOGIES LTD

0.3125
-0.0053-1.68%
Post-market: 0.31250.00000.00%16:10 EDT
Volume:30.87K
Turnover:10K
Market Cap:5.91M
PE:-0.30
High:0.3200
Open:0.3140
Low:0.3000
Close:0.3178
52wk High:3.18
52wk Low:0.2699
Shares:18.91M
Float Shares:8.36M
Volume Ratio:0.80
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0280
EPS(LYR):-0.9415
ROE:-151.99%
ROA:-61.34%
PB:1.21
PE(LYR):-0.33

Loading ...

CollPlant Biotechnologies Holds Extraordinary Shareholder Meeting

Reuters
·
Aug 19

CollPlant Biotechnologies Holds Extraordinary Shareholder Meeting

Reuters
·
Jul 29

CollPlant Biotechnologies Files Prospectus for Resale of 31 Million Shares

MT Newswires Live
·
Jul 10

Collplant Biotechnologies Announces Extraordinary Shareholder Meeting

Reuters
·
Jul 08

Collplant Prices USD 2.6 Million Private Placement at USD 0.34 Per Share

Reuters
·
Jun 30

Press Release: Collplant Biotechnologies Announces $2.6 Million Private Placement

Dow Jones
·
Jun 30

CollPlant Biotechnologies Q1 Adj. EPS $(0.21) Misses $(0.19) Estimate, Sales $73.000K Miss $1.100M Estimate

Benzinga Earnings
·
May 29

CollPlant Q1 FY26 net loss widens to USD 3.1 million; revenue drops to USD 73,000

Reuters
·
May 29

Press Release: COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Dow Jones
·
May 29

CollPlant files Form 3 for director Hugh M. Evans initial beneficial ownership statement

Reuters
·
Apr 28

CollPlant plans 50% workforce cut to extend cash runway into Q4 2026

Reuters
·
Apr 13

CollPlant makes shareholder letter available

Reuters
·
Apr 13

CollPlant files to sell 3.3M ordinary shares for holders

TIPRANKS
·
Mar 31

Collplant Biotechnologies Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 26

CollPlant Biotechnologies Q4 Adj. EPS $(0.25) Misses $(0.19) Estimate, Sales $60.000K Miss $1.524M Estimate.

Benzinga Earnings
·
Mar 26

CollPlant FY2025 revenue more than tripled to $2.4 million; net loss narrows to $11.5 million

Reuters
·
Mar 26

Press Release: COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Dow Jones
·
Mar 26

CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Profit Outlook

Simply Wall St.
·
Mar 25

CollPlant receives non-compliance letter from Nasdaq

TIPRANKS
·
Mar 25

CollPlant gets Nasdaq notice after shares trade below $1 for 30 days

Reuters
·
Mar 25